The ???Uber of Biotech??? Gets Back To Work

Hilary Kramer discusses biotech stocks, outlines their risks and compares the industry leader to Uber.

  • by:
  • 08/21/2022
ad-image

By Hilary Kramer

Forget the ???FANG??? group of the biggest technology companies. When you want pure disruptive innovation and a wild Wall Street ride, biotech remains the place to be.

I love these stocks. When they???re rallying, they???re a play on pure innovation. This is because they generate wealth for shareholders on what boils down to the confidence that medical science will keep advancing.

The upside is practically infinite. After all, most computer tools only improve life in increments, make us a little more productive day by day and expand our existing reach.

Biotech, at its most visionary, saves human lives that otherwise would be cut short one way or another. That transcends normal valuations.

Companies that develop those therapies can one day be worth the price of progress itself. And when that mood catches on, the stocks soar.

We???ve seen a few of these stocks on my Turbo Trader list soar 50 percent year to date. That???s true transformative upside. It???s exhilarating.

Click here to read more.

Image:
ADVERTISEMENT

Opinion

View All

JACK POSOBIEC: Trump's 'Great Deal' will overhaul the economy for the American worker

"This is the path that leads to the return of the American dream. Ladies and gentlemen, welcome to th...

DANIEL HAYWORTH: Hegseth's vision of one strong standard is right for the military

Hegseth’s order acknowledges what countless military members will tell you: A unified standard is not...

Billboard Chris and X challenge radical gender ideology-based censorship in Australian court case, now under way

“My case is an example of the free speech crisis here in Australia and across the West... Gender ideo...